Abstract
The analysis of longitudinal series of tumour markers during chemotherapy in patients with germ cells tumors is not easy. The purpose of this work is to present various characteristic profiles of the evolution of serum human chorionic gonadotropin during chemotherapy and review the modalities of the dynamic interpretation of this marker.
MeSH terms
-
Adult
-
Antibiotics, Antineoplastic / administration & dosage
-
Antineoplastic Agents, Alkylating / administration & dosage
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor*
-
Bleomycin / administration & dosage
-
Bone Marrow Transplantation
-
Carboplatin / administration & dosage
-
Chorionic Gonadotropin / blood*
-
Chorionic Gonadotropin / metabolism
-
Cisplatin / administration & dosage
-
Etoposide / administration & dosage
-
Follow-Up Studies
-
Half-Life
-
Humans
-
Ifosfamide / administration & dosage
-
Lung Neoplasms / secondary
-
Lymphatic Metastasis
-
Male
-
Neoplasm Metastasis
-
Neoplasms, Germ Cell and Embryonal / blood
-
Neoplasms, Germ Cell and Embryonal / drug therapy*
-
Paclitaxel / administration & dosage
-
Remission Induction
-
Testicular Neoplasms / blood
-
Testicular Neoplasms / drug therapy*
-
Transplantation, Autologous
-
Treatment Outcome
-
Young Adult
Substances
-
Antibiotics, Antineoplastic
-
Antineoplastic Agents, Alkylating
-
Antineoplastic Agents, Phytogenic
-
Biomarkers, Tumor
-
Chorionic Gonadotropin
-
Bleomycin
-
Etoposide
-
Carboplatin
-
Paclitaxel
-
Cisplatin
-
Ifosfamide